Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Geisler, Jürgen, Haynes, Ben, Anker, Gun, Dowsett, Mitch, Lønning, Per Eystein·2002·Journal of Clinical Oncology
DOI 10.1200/jco.20.3.751

Cited by (606)

Items 501–600 of 606

  1. Breast Cancer
    Richard J. Santen · 2009 · Elsevier eBooks
  2. Hormonal Regulation of Vaginal Mucosa
    Theodora Kunovac Kallak · 2015
  3. Breast Cancer in Elderly Women
    Monica Morrow, Oriana Petruolo · 2017 · Springer eBooks
  4. The third-generation aromatase inhibitors: a clinical overview
    Aman U. Buzdar · 2006 · Birkhäuser-Verlag eBooks
  5. Comparison Between Letrozole With and Without Gonadotropins Injection on Pregnancy Rates in Infertile PCOS Patients : A Multicenter Randomized Observational Trial
    Hamada Ashry Abdel Wahed Ali, Thoraya Aly, Ahmed Adel Ragab · 2022 · Evidence Based Women s Health Journal
  6. Uso de inibidores da aromatase para melhora estatural em meninos: uma revisão literária
    Mauren Oliveira Cruz, Adriana Resende Milagres Saab · 2023 · Research Society and Development
  7. Ineffective Inhibition of Aromatase: A Cause for AI Resistance?
    Per Eystein Lønning · 2015 · Resistance to targeted anti-cancer therapeutics
  8. Description and Pre-clinical Validation of Dynamic Molecular Determinants of Sensitivity to Aromatase Inhibitors in Breast Cancer
    Ander Urruticoechea Ribate · 2008 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  9. Effects of chemotherapy-induced ovarian failure on bone and lipid metabolism in premenopausal breast cancer patients : Impact of adjuvant clodronate and tamoxifen
    Leena Vehmanen · 2005 · Työväentutkimus Vuosikirja
  10. Development of a non-steroidal aromatase inhibitor-based protocol for the control of ovarian function using a bovine model
    Maria Jimena Yapura · 2013 · HARVEST (University of Saskatchewan)
  11. Understanding female social dominance: Comparative behavioral endocrinology in the Genus Eulemur
    Joseph M. A. Petty · 2015 · DukeSpace (Duke University)
  12. Adjuvant endocrine therapy options in hormone-dependent breast cancer
    Kathrin Strasser‐Weippl, Paul Edward Goss · 2005 · European Journal of Cancer Supplements
  13. David Kupfer and the Metabolism Connection: On Aromatase Inhibitors and Tamoxifen
    Angela M. H. Brodie · 2006 · Drug Metabolism Reviews
  14. Advances in the Adjuvant and Neoadjuvant Treatment of Breast Cancer
    Susanne Briest, Vered Stearns · 2007 · Women s Health
  15. Aromatase inhibitors in advanced breast cancer: there are efficacy differences
    Ajay S. Bhatnagar · 2005 · British Journal of Cancer
  16. The Letrozole Breast Cancer Trial: clinical implications and remaining questions
    Wendy Y. Chen, JoAnn Elisabeth Manson · 2004 · Women s Health Issues
  17. Postmenopausal Metastatic Breast Cancer
    L. Assersohn, Stephen R.D. Johnston · 2003 · American Journal of Cancer
  18. Aromatase inhibitors forfemaleinfertility treatment
    Vedat Atay, Hakan Yaralı́, Gürkan Bozdağ, Gökhan Özışık, Demet Akin, Murat Muhçu · 2007 · Expert Opinion on Therapeutic Patents
  19. Breast Cancer: Side Effects of Tamoxifen and Anastrozole
    John R. Benson, Eleanor H. Turner, Zoë Winters · 2008 · Springer eBooks
  20. Inhibitory actions of Ah receptor agonists and indole-containing compounds in breast cancer cell lines and mouse models
    Kelcey Walker · 2005 · OakTrust (Texas A&M University Libraries)
  21. Phase 1–Phase 3 Clinical Studies, Procedures, Responsibilities, and Documentation
    Souzan B. Yanni · 2015 · Wiley eBooks
  22. The nuclear factor kappa b (NFkb) plays a critical role in the development of antiestrogen resistance
    Ruchi Nehra · 2009 · DigitalGeorgetown (Georgetown University Library)
  23. Letrozole versus Tamoxifen as First-Line Treatment for Metastatic Breast Cancer
    Henning T. Mouridsen · 2003 · American Journal of Cancer
  24. ER-Alpha36 Mediates Non-Genomic Estrogen and Anti-Estrogen Signaling in Breast Cancer Cells
    Zhaoyi Wang, XianTian Zhang, Lianguo Kang · 2011 · InTech eBooks
  25. Inhibition of steroidogenic cytochrome P450 enzymes as treatments for the related hormone dependent diseases
    Qingzhong Hu · 2010 · Publications of the UdS (Saarland University)
  26. Elektronenmikroskopische Untersuchungen zur Dichte von Spinesynapsen in hippocampalen Schnittkulturen nach Behandlung mit Substraten der Östrogensynthese
    Richard von Lossow · 2009
  27. Clinical studies with anastrozole
    Anthony Howell, Alan E. Wakeling · 2008 · Birkhäuser Basel eBooks
  28. Breast Cancer in Elderly Women
    Monica Morrow, Lisa Wiechmann · 2011 · Springer eBooks
  29. Non-steroidal CYP enzyme inhibitors as potential treatments for corticoid and estrogen related diseases
    Lina Yin · 2011 · Publications of the UdS (Saarland University)
  30. Clinical pharmacology of aromatase inhibitors
    Jürgen Geisler, Per Eystein Lønning · 2008 · Birkhäuser Basel eBooks
  31. Endocrine Therapy in the Preoperative Setting and Strategies to Overcome Resistance
    Saranya Chumsri, Angela Brodie · 2011 · Current Breast Cancer Reports
  32. Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
    Per Eystein Lønning, Jürgen Geisler · 2006 · Nature Clinical Practice Oncology
  33. Aromatasehemmer in der Therapie der Endometriose
    I Juhasz-Böss, Oliver Treeck, Eduard Malik, Olaf Ortmann · 2006 · Gynäkologische Endokrinologie
  34. Time for a change in breast cancer therapy?
    David Cameron · 2004 · Hospital Medicine
  35. Skeletal events of Anastrozole versus Tamoxifen on bone mineral density and bone biomarker osteocalcin in postmenopausal women with early breast cancer
    Lobna R. Ezz El Arab, Menha M. Swellam, M. M. Abdel Wahab, Karima Moustafa Maher · 2010 · The Chinese-German Journal of Clinical Oncology
  36. Reply to ‘Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature’ by Delea et al.
    Per Eystein Lønning · 2006 · Annals of Oncology
  37. The Evolving Role of Aromatase Inhibitors in the Adjuvant Breast Cancer Setting
    Paul Edward Goss · 2003 · American Journal of Cancer
  38. Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors?
    Alice Dewdney and Sarah Needleman · 2010 · Clinical Medicine Reviews in Oncology
  39. Effects of Drug Treatment for Malignancy on Skeletal Health of Cancer Survivors
    Ailleen Heras-Herzig, Theresa A. Guise · 2004 · Clinical Reviews in Bone and Mineral Metabolism
  40. Endocrine therapy in locally recurrent and metastatic breast cancer
    Ulla Brix Tange, Henning T. Mouridsen · 2003 · European Journal of Cancer Supplements
  41. Personalized medicine for breast cancer: dream or reality?
    Lina Pugliano, Dimitrios Zardavas, Martine J Piccart · 2013 · memo - Magazine of European Medical Oncology
  42. Potential use of aromatase inhibitors in gynecology
    Julie Lukic, Togas Tulandi · 2006 · Expert Review of Obstetrics & Gynecology
  43. Implications of First-Line Adjuvant Treatment with Aromatase Inhibitors in Recurrent Metastatic Breast Cancer
    Lisa E. Sokolowicz, William John Gradishar · 2004 · Clinical Breast Cancer
  44. Anastrozole Versus Exemestane in Patients with Postmenopausal Breast Cancer and Visceral Metastases
    Postmenopausal Breast Cancer, Visceral Metastases, Jasgit C. Sachdev, Andrew M. Schreiber, Mohammad Jahanzeb · 2010 · Clinical Medicine Reviews in Oncology
  45. Anastrozole therapy for postmenopausal women with early breast cancer
    Jean‐Marc Nabholtz · 2007 · Expert Review of Obstetrics & Gynecology
  46. Adjuvant trials: Aromatase inhibitors in early breast cancer – Are they alike?
    Alain Monnier · 2006 · Cancer Treatment Reviews
  47. Cancer treatment‐induced bone loss: A review
    Frances Sarah Barnett, Richard DE BOER · 2006 · Asia-Pacific Journal of Clinical Oncology
  48. The Impact of Hormone Receptor Status on the Clinical Efficacy of the New-Generation Aromatase Inhibitors: A Review of Data From First-Line Metastatic Disease Trials in Postmenopausal Women
    Aruna Kommareddy, M.J. Ellis · 2005 · Breast Diseases A Year Book Quarterly
  49. Use of aromatase inhibitors in gynecology
    Intisar M Elnahhas, M.F. Mitwally · 2010 · Expert Review of Obstetrics & Gynecology
  50. Certitudes et interrogations concernant les inhibiteurs d'aromatase
    Jacques M Bonneterre · 2004 · DSpace (Centre National De La Recherche Scientifique)
  51. Aromatase Inhibitors in the Adjuvant Treatment of Postmenopausal Women with Early Stage Breast Cancer
    Jennifer A. Ligibel, Eric P. Winer · 2005 · Women s Health
  52. Economic evaluation of aromatase inhibitors for the treatment of breast cancer
    Amin Majid Alousi, Miron Stano, Michael Steven Simon · 2003 · Expert Review of Pharmacoeconomics & Outcomes Research
  53. Clinical studies with letrozole
    J. Michael Dixon · 2006 · Birkhäuser-Verlag eBooks
  54. Endocrine symptoms to predict risk of recurrence
    Fabrice Barlési · 2008
  55. ESTUDO DO BIOMARCADOR P16 NO CARCINOMA DE MAMA DE MULHERES SUBMETIDAS À ENDOCRINOTERAPIA PRIMÁRIA DE CURTA DURAÇÃO COM TAMOXIFENO E ANASTROZOL
    Alexandre S. Melitto · 2009 · Americanae (AECID Library)
  56. MicroRNA Sequencing of Long-Term Estrogen Deprived Breast Cancer Cells Reveals a Potential Role for miR-181a in Estrogen-Independent Growth
    Erin Hayes · 2015 · KU ScholarWorks (The University of Kansas)
  57. The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
    Jennifer A. Ligibel, Eric P. Winer · 2003 · Journal of the National Comprehensive Cancer Network
  58. Antitumorale Wirkungen und Nebenwirkungen von Aromatasehemmern
    Claus Lattrich, I Juhasz-Böss, Felicitas Horn, Olaf Ortmann · 2005 · Gynäkologische Endokrinologie
  59. Reducing the risk of recurrence in postmenopausal women with early breast cancer: a role for aromatase inhibitors
    Nicholas J. Robert · 2006 · Community Oncology
  60. Investigation of the mechanisms of estrogen receptor activation by phosphorylation
    Amy Catherine Halliday · 2009 · Spiral (Imperial College London)
  61. Einfluss von 17-ß-Östradiol auf die Spinesynapsendichte in der Molekularschicht des Gyrus dentatus
    Gabriele M. Rune · 2012
  62. Novel Translational Research of Neo-adjuvant Endocrine Therapy
    Alexey A. Larionov · 2016 · Springer eBooks
  63. Aromatase Inhibitors for Breast Cancer Treatment and Prevention
    Erica L. Mayer, Eric P. Winer · 2007 · Translational medicine series
  64. Suppression of Prostate Carcinogenesis by Tea Polyphenols through Inhibiting Microsomal Aromatase and 5_lpha-Reductase
    Jen‐Kun Lin · 2008 · Nutraceutical science and technology
  65. Primary Endocrine Therapy
    2009 · Infoma healthcare eBooks
  66. ADVANCES WITH AROMATASE INHIBITORS
    Saranya Chumsri, Ting Bao, Gauri J. Sabnis, Angela M. H. Brodie · 2013 · IMPERIAL COLLEGE PRESS eBooks
  67. Skeletal Complications: Bone Metabolism and Novel Targeted Agents
    Alissa J. Huston · 2008 · CRC Press eBooks
  68. The effect of Tamoxifen and Fulvestrant on pro-inflammatory markers in oestrogen receptor positive breast cancer
    Anna S. Amiss · 2016 · Otago University Research Archive (University of Otago)
  69. Cognitive Function in Post-Menopausal Women with Breast Cancer Treated with Aromatase Inhibitors.
    Patricia M. Clark · 2014 · Deep Blue (University of Michigan)
  70. Effects of breast cancer hormone treatment on lipids and subsequent cardiovascular diseases
    Hsin-Hui Huang · 2017 · D-Scholarship@Pitt (University of Pittsburgh)
  71. Cognitive Sequelae of Endocrine Therapy for the Treatment of Breast Cancer
    E. A. Underwood · 2017 · TSpace (University of Toronto)
  72. Considerations on the Use of Aromatase Inhibitors in Postmenopausal Women With Breast Cancer
    Jeffrey D. Blaustein · 2020 · Oxford University Press eBooks
  73. Clinical pharmacology of aromatase inhibitors
    Jürgen Geisler, Per Eystein Lønning · 2006 · Birkhäuser-Verlag eBooks
  74. Adjuvant Systemic Therapy: Endocrine Therapy
    İbrahim Yıldız, Pınar Mualla Saip · 2019 · Springer eBooks
  75. Endocrine Therapy for Breast Cancer
    Seema Harichand-Herdt, Amelia Bruce Zelnak, Ruth M O'Regan · 2009 · Elsevier eBooks
  76. Breast Cancer in Elderly Women
    Monica Morrow, Oriana Petruolo · 2020 · Springer eBooks
  77. Endocrine Therapy
    Sacha Jon Howell, Anthony Howell · 2010 · Springer eBooks
  78. Endocrine therapy of breast cancer
    Rosalba Torrisi, Alessandra Balduzzi, Aron Goldhirsch · 2007 · Birkhäuser Basel eBooks
  79. Treatment of Metastatic Breast Cancer: Endocrine Therapy
    Fatma Şen, Adnan Aydıner · 2019 · Springer eBooks
  80. Clinical studies with letrozole
    J. Michael Dixon · 2008 · Birkhäuser Basel eBooks
  81. Memory and Epigenetics: Role of Estrogen
    Jennifer J. Tuscher, Ashley M. Fortress, Karyn M. Frick · 2018 · Elsevier eBooks
  82. Clinical studies with anastrozole
    Anthony Howell, Alan E. Wakeling · 2006 · Birkhäuser Basel eBooks
  83. Endocrine therapy for advanced disease
    Stephen R.D. Johnston · 2011 · Informa Healthcare eBooks
  84. Induction of ovulation in women with PCOS using letrozole versus letrozole plus gonadotropin and its effect on spontaneous on going pregnancy rate through multicenter IVF in Beni-Suef city using randomized controlled study
    Hamada Ashry Abdel Wahed Ali, Thoraya Aly, Ahmed Ragab Ali, Eman M. Khalil · 2022 · International Journal of Health Sciences
  85. Salute ossea in corso di trattamento adiuvante anti-ormonale nella patologia oncologica: rischio fratturativo e temporizzazione della terapia
    Morena Pisarro, Francesco Conti · 2022 · L Endocrinologo
  86. Unravelling the role of signal transduction pathways in high-grade serous carcinogenesis
    Phyllis van der Ploeg · 2023
  87. Rheumatic aspects of arthralgias associated with aromatase inhibitor therapy (analysis of a clinical case series)
    Анастасия Дмитриевна Колтакова, Aleksander M. Lila, Olga G. Alekseeva · 2023 · Modern Rheumatology Journal
  88. Data from Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer
    Zara F. Ghazoui, Francesca Meteora Buffa, Anita K. Dunbier, H Anderson, Tim Dexter, Simone I. DETRE, Janine Salter, Ian E. Smith, Adrian Llewellyn Harris, Mitch Dowsett · 2023
  89. Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
    Cesar Augusto Santa-Maria, Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich, James Michael Rae, Zeruesenay Desta, Jason Robarge, Norah Lynn Henry et al. · 2023
  90. Supplementary Data from Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer
    Zara F. Ghazoui, Francesca Meteora Buffa, Anita K. Dunbier, H Anderson, Tim Dexter, Simone I. DETRE, Janine Salter, Ian E. Smith, Adrian Llewellyn Harris, Mitch Dowsett · 2023
  91. AROMATASE INHIBITION ACTIVITY OF CITRUS FRUITS AGAINST BREAST CANCER
    2023 · International Research Journal of Modernization in Engineering Technology and Science
  92. Letrozole ameliorates fructose-induced hyperlipidaemia and uric acid accumulation in male Wistar rats
    Adam Olaitan Abdulkareem, Emmanuel Olusegun Abe, Adeola Adefoluke Ala, Lawrence A. Olatunji · 2023 · Physiology and Pharmacology
  93. Comparison between Letrozole with and without Gonadotropins Injection on Pregnancy Rates in Infertile PCOS Patients: A Multicenter Randomized Observational Trial
    Ali Hamada A A, Thoraya Aly, Ali Ahmed Ragab · 2023
  94. Concurrent versus sequential hormonal and radiotherapy in postmenopausal women with early breast cancer
    Asmaa A. Abdeltawab, Samia Abd El-Fattah Ali, Hanan Gamal-Eldeen Mostafa, Mohamed A. E. Hassan · 2024 · Indian Journal of Cancer
  95. Clonal selection supported by single cell Dna sequencing reveals hormonal adaptation and resistance in locally advanced breast cancer During Neoadjuvant Aromatase Inhibition
    Denise G O'Mahony, Tom Lesluyes, Ina Skaara Brorson, Patrik Vernhoff, Ksenia Sokolova, Miriam R. R. Aure, Grethe Grenaker Alnæs, Rebecca Mae Hooen, Arvind Y.M. Sundaram, Chandra L. Theesfeld et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Pharmacocinétique et pharmacogénétique du tamoxifène et du létrozole chez les patientes atteintes d’un cancer du sein hormonodépendant
    Alicja Puszkiel · 2019 · theses.fr (ABES)
  97. Management of Bone Health in Breast Cancer Survivors
    Kumar Shivam, J. Allen, Faisal Aljabrain, Karma-Jaya Elliott, Jairam Krishnamurthy, Kristen C. Kelley · 2026 · JCO Oncology Practice
  98. Antiestrogenic therapy effect on brain structure and mental health in women with breast cancer: a longitudinal MRI study
    Serenay Yazıcı, Berfin Gülbahçe, Ann-Christin Sophie Kimmig, Sara Y. Brucker, Benjamin Bender, Uta Hoopmann, Markus Hahn, Anna Wikman, Birgit Derntl · 2026 · medRxiv
  99. Aromatase inhibitors as endocrine modulators: From breast cancer therapy to male off-label use and doping practice
    Andrej Bandura, Pavol Ďurina, Enrico Cambal, Štefan Kečkéš · 2026 · The Journal of Steroid Biochemistry and Molecular Biology
  100. Design, synthesis, and cytotoxic activity evaluation of 1,2,4-Triazole-based Ethanone and Ferrocenylchalcone derivatives: A comparative study
    Nuran Kahriman, Ali Aydın, Sıla Can Osmanoğulları, Fatma Demir, Olcay Bekircan · 2026 · Bioorganic Chemistry